Thermo Fisher and Flagship announced the formation of a strategic partnership to develop and commercially scale multiproduct platforms on an accelerated basis. Through this collaboration, Thermo Fisher and Flagship will work together to create new platform companies focusing on novel tools and capabilities that seek to power the biotech ecosystem and accelerate the development of first-in-class therapies. The newly formed strategic partnership is an expansion of the long-standing supply relationship between Thermo Fisher and Flagship, which extends to Flagship’s ecosystem of companies and leverages the expertise of both organizations including the areas of life science tools, diagnostics, and services.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher announces $4B share repurchase program
- 5 Top Value Stocks to Buy Now, According to Analysts – November 2023
- Novo hires Fujifilm unit to fill Wegovy injection pens, Reuters reports
- Repligen price target lowered to $210 from $240 at KeyBanc
- Microsoft upgraded, F5 Networks downgraded: Wall Street’s top analyst calls